SOURCE: Given Imaging

February 22, 2006 08:30 ET

Given Imaging to Present at the Citigroup Healthcare Conference

YOQNEAM, ISRAEL -- (MARKET WIRE) -- February 22, 2006 --Given Imaging Ltd. (NASDAQ: GIVN) today announced that Yuval Yanai, Chief Financial Officer of Given Imaging, will present at the Citigroup Healthcare Conference taking place February 27 - March 1 in Washington D.C. Mr. Yanai's presentation is scheduled for Tuesday, February 28 at 10:20am ET.

To access a live webcast of Mr. Yanai's presentation, visit www.givenimaging.com. A replay of the webcast will be available for thirty days at the above referenced website.

About Given Imaging

Given Imaging is redefining gastrointestinal diagnosis by developing, producing and marketing innovative, patient-friendly products for detecting gastrointestinal disorders. The company is developing a complete line of PillCam™ video capsules for detecting disorders of the gastrointestinal tract. The company's technology platform is the Given® Diagnostic System, featuring the PillCam video capsule, a disposable, miniature video camera contained in a capsule, which is ingested by the patient. The PillCam™ SB capsule is the only naturally ingested method for direct visualization of the entire small intestine. It is currently marketed in the United States and in more than 50 other countries and has benefited more than 300,000 patients worldwide. The PillCam™ ESO video capsule, which provides visual examination of the esophagus, has been cleared for marketing by the FDA. Additional capsules for visualization of the stomach and colon are under development. Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel; it has direct sales and marketing operations in the United States, Germany and France, and local offices in Japan, Spain and Australia. For more information, visit http://www.givenimaging.com.

This press release contains forward-looking statements about Given Imaging, including projections about our business and our future revenues, expenses and profitability, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, words such as "anticipates," "estimates," "expects," "intends," "plans," "believes," and words and terms of similar substance used in connection with any discussion of future operating or financial performance identify such forward-looking statements. Those forward-looking statements are not guarantees of future performance and actual results could differ materially from our current expectations as a result of numerous factors, including but not limited to the following: changes in regulatory environment, our success in implementing our sales, marketing and manufacturing plan, protection and validity of patents and other intellectual property rights, the impact of currency exchange rates, the effect of competition by other companies, the outcome of future litigation, the reimbursement policies for our product from healthcare payors, quarterly variations in operating results, the impact of the newly adopted SFAS 123R for expensing option-based payments, the possibility of armed conflict or civil or military unrest in Israel and other risks disclosed in our filings with the U.S. Securities and Exchange Commission.

Contact Information

  • For further information contact:
    Fern Lazar
    David Carey
    Lazar Partners Ltd.
    Phone: (866) GIVEN IR
    Email Contact
    Email Contact

    Yuval Yanai
    Given Imaging Ltd.